Heidelberg Pharma AG Share Price Deutsche Boerse AG
Equities
HPHA
DE000A11QVV0
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.97 EUR | +0.68% | +2.06% | -18.63% |
04-25 | Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
04-23 | Transcript : Heidelberg Pharma AG - Special Call |
Sales 2024 * | 11.5M 12.38M 987M | Sales 2025 * | 15M 16.15M 1.29B | Capitalization | 139M 150M 11.91B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 12.1 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 9.26 x |
P/E ratio 2024 * |
-9.93
x | P/E ratio 2025 * |
-22.9
x | Employees | 98 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 16.94% |
Latest transcript on Heidelberg Pharma AG
1 day | +2.37% | ||
1 week | +2.06% | ||
1 month | -2.94% | ||
3 months | -5.71% | ||
6 months | +11.65% | ||
Current year | -18.63% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Pahl
CEO | Chief Executive Officer | - | 31/12/11 |
Walter Miller
DFI | Director of Finance/CFO | - | 30/04/23 |
András Strassz
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 28/04/05 | |
Georg F. Baur
BRD | Director/Board Member | 74 | 13/12/00 |
Birgit Kudlek
BRD | Director/Board Member | 57 | 24/05/12 |
Date | Price | Change | Volume |
---|---|---|---|
03/05/24 | 2.97 | +0.68% | 0 |
02/05/24 | 2.95 | -0.67% | 0 |
30/04/24 | 2.97 | +1.37% | 0 |
29/04/24 | 2.93 | +0.69% | 0 |
26/04/24 | 2.91 | -1.02% | 0 |
Delayed Quote Deutsche Boerse AG, May 03, 2024 at 08:49 pm
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.38% | 103B | |
+8.83% | 101B | |
+4.40% | 23.07B | |
-12.11% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.03% | 16.94B | |
+6.81% | 14.07B | |
+38.58% | 12.35B |
- Stock Market
- Equities
- HPHA Stock
- HPHA Stock